Factors associated with reluctancy to acquire COVID-19 vaccination: A cross-sectional study in Shiraz, Iran, 2022
Vaccination is a crucial action that can end the COVID-19 pandemic and reduce its detrimental effect on public health. Despite the availability of various vaccines, this study was conducted to better understand the factors behind individuals refusing to get vaccinated. The current cross-sectional st...
Saved in:
| Published in | PloS one Vol. 17; no. 12; p. e0278967 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science
12.12.2022
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1932-6203 1932-6203 |
| DOI | 10.1371/journal.pone.0278967 |
Cover
| Abstract | Vaccination is a crucial action that can end the COVID-19 pandemic and reduce its detrimental effect on public health. Despite the availability of various vaccines, this study was conducted to better understand the factors behind individuals refusing to get vaccinated.
The current cross-sectional study was conducted with individuals above 18 years of age in Shiraz, Iran, who were eligible but refused to receive the COVID-19 vaccination. Demographic features and factors related to their hesitancy and willingness to participate in the vaccination program were recorded in a questionnaire.
Out of 801 participants in the current study, 427 (53.3%) were men, with a mean age of 37.92 years (± 14.16). The findings revealed that 350 (43.7%) participants claimed the side effects of the vaccine outweigh the benefits as one reason for their reluctance toward COVID-19 vaccination, followed by the unknown efficacy of vaccines (40.4%) and a lack of trust in vaccine companies (32.8%). Ensuring the safety of the vaccine (43.7%) and verifying its effectiveness (34.5%) were the most prevalent factors behind participating in the vaccination program. Those who reported their socio-economic status as low were significantly reluctant toward vaccination because of a self-presumption of high immunity (p-value < 0.001), the unclear efficacy of vaccines (p-value < 0.001), the side effects outweighing the benefits of vaccines (p-value < 0.001), distrust of vaccine companies (p-value < 0.001), usage of mask, gloves, and sanitizers (p-value < 0.001), contradictory speech of health authorities regarding vaccines (p-value = 0.041), and the unavailability of trusted vaccines (p-value = 0.002). It should also be noted that participants reported a greater likelihood to obtain information about vaccination reluctance from family and friends (p-value <0.001) and complementary medicine professionals (p-value <0.001).
Avoiding vaccination is an undeniable public and individual health concern in Iran, as demonstrated in the current study. Concern about vaccine efficacy and side effects is the most reported cause of vaccination reluctance among individuals, which could be altered by emphasizing mass education and averting an infodemic by forming dedicated multidisciplinary organizations. |
|---|---|
| AbstractList | Background Vaccination is a crucial action that can end the COVID-19 pandemic and reduce its detrimental effect on public health. Despite the availability of various vaccines, this study was conducted to better understand the factors behind individuals refusing to get vaccinated. Method The current cross-sectional study was conducted with individuals above 18 years of age in Shiraz, Iran, who were eligible but refused to receive the COVID-19 vaccination. Demographic features and factors related to their hesitancy and willingness to participate in the vaccination program were recorded in a questionnaire. Result Out of 801 participants in the current study, 427 (53.3%) were men, with a mean age of 37.92 years (± 14.16). The findings revealed that 350 (43.7%) participants claimed the side effects of the vaccine outweigh the benefits as one reason for their reluctance toward COVID-19 vaccination, followed by the unknown efficacy of vaccines (40.4%) and a lack of trust in vaccine companies (32.8%). Ensuring the safety of the vaccine (43.7%) and verifying its effectiveness (34.5%) were the most prevalent factors behind participating in the vaccination program. Those who reported their socio-economic status as low were significantly reluctant toward vaccination because of a self-presumption of high immunity (p-value < 0.001), the unclear efficacy of vaccines (p-value < 0.001), the side effects outweighing the benefits of vaccines (p-value < 0.001), distrust of vaccine companies (p-value < 0.001), usage of mask, gloves, and sanitizers (p-value < 0.001), contradictory speech of health authorities regarding vaccines (p-value = 0.041), and the unavailability of trusted vaccines (p-value = 0.002). It should also be noted that participants reported a greater likelihood to obtain information about vaccination reluctance from family and friends (p-value <0.001) and complementary medicine professionals (p-value <0.001). Conclusion Avoiding vaccination is an undeniable public and individual health concern in Iran, as demonstrated in the current study. Concern about vaccine efficacy and side effects is the most reported cause of vaccination reluctance among individuals, which could be altered by emphasizing mass education and averting an infodemic by forming dedicated multidisciplinary organizations. Background Vaccination is a crucial action that can end the COVID-19 pandemic and reduce its detrimental effect on public health. Despite the availability of various vaccines, this study was conducted to better understand the factors behind individuals refusing to get vaccinated. Method The current cross-sectional study was conducted with individuals above 18 years of age in Shiraz, Iran, who were eligible but refused to receive the COVID-19 vaccination. Demographic features and factors related to their hesitancy and willingness to participate in the vaccination program were recorded in a questionnaire. Result Out of 801 participants in the current study, 427 (53.3%) were men, with a mean age of 37.92 years (± 14.16). The findings revealed that 350 (43.7%) participants claimed the side effects of the vaccine outweigh the benefits as one reason for their reluctance toward COVID-19 vaccination, followed by the unknown efficacy of vaccines (40.4%) and a lack of trust in vaccine companies (32.8%). Ensuring the safety of the vaccine (43.7%) and verifying its effectiveness (34.5%) were the most prevalent factors behind participating in the vaccination program. Those who reported their socio-economic status as low were significantly reluctant toward vaccination because of a self-presumption of high immunity ( p- value < 0.001), the unclear efficacy of vaccines ( p- value < 0.001), the side effects outweighing the benefits of vaccines ( p- value < 0.001), distrust of vaccine companies ( p- value < 0.001), usage of mask, gloves, and sanitizers ( p- value < 0.001), contradictory speech of health authorities regarding vaccines ( p- value = 0.041), and the unavailability of trusted vaccines ( p- value = 0.002). It should also be noted that participants reported a greater likelihood to obtain information about vaccination reluctance from family and friends ( p- value <0.001) and complementary medicine professionals ( p- value <0.001). Conclusion Avoiding vaccination is an undeniable public and individual health concern in Iran, as demonstrated in the current study. Concern about vaccine efficacy and side effects is the most reported cause of vaccination reluctance among individuals, which could be altered by emphasizing mass education and averting an infodemic by forming dedicated multidisciplinary organizations. Vaccination is a crucial action that can end the COVID-19 pandemic and reduce its detrimental effect on public health. Despite the availability of various vaccines, this study was conducted to better understand the factors behind individuals refusing to get vaccinated.BACKGROUNDVaccination is a crucial action that can end the COVID-19 pandemic and reduce its detrimental effect on public health. Despite the availability of various vaccines, this study was conducted to better understand the factors behind individuals refusing to get vaccinated.The current cross-sectional study was conducted with individuals above 18 years of age in Shiraz, Iran, who were eligible but refused to receive the COVID-19 vaccination. Demographic features and factors related to their hesitancy and willingness to participate in the vaccination program were recorded in a questionnaire.METHODThe current cross-sectional study was conducted with individuals above 18 years of age in Shiraz, Iran, who were eligible but refused to receive the COVID-19 vaccination. Demographic features and factors related to their hesitancy and willingness to participate in the vaccination program were recorded in a questionnaire.Out of 801 participants in the current study, 427 (53.3%) were men, with a mean age of 37.92 years (± 14.16). The findings revealed that 350 (43.7%) participants claimed the side effects of the vaccine outweigh the benefits as one reason for their reluctance toward COVID-19 vaccination, followed by the unknown efficacy of vaccines (40.4%) and a lack of trust in vaccine companies (32.8%). Ensuring the safety of the vaccine (43.7%) and verifying its effectiveness (34.5%) were the most prevalent factors behind participating in the vaccination program. Those who reported their socio-economic status as low were significantly reluctant toward vaccination because of a self-presumption of high immunity (p-value < 0.001), the unclear efficacy of vaccines (p-value < 0.001), the side effects outweighing the benefits of vaccines (p-value < 0.001), distrust of vaccine companies (p-value < 0.001), usage of mask, gloves, and sanitizers (p-value < 0.001), contradictory speech of health authorities regarding vaccines (p-value = 0.041), and the unavailability of trusted vaccines (p-value = 0.002). It should also be noted that participants reported a greater likelihood to obtain information about vaccination reluctance from family and friends (p-value <0.001) and complementary medicine professionals (p-value <0.001).RESULTOut of 801 participants in the current study, 427 (53.3%) were men, with a mean age of 37.92 years (± 14.16). The findings revealed that 350 (43.7%) participants claimed the side effects of the vaccine outweigh the benefits as one reason for their reluctance toward COVID-19 vaccination, followed by the unknown efficacy of vaccines (40.4%) and a lack of trust in vaccine companies (32.8%). Ensuring the safety of the vaccine (43.7%) and verifying its effectiveness (34.5%) were the most prevalent factors behind participating in the vaccination program. Those who reported their socio-economic status as low were significantly reluctant toward vaccination because of a self-presumption of high immunity (p-value < 0.001), the unclear efficacy of vaccines (p-value < 0.001), the side effects outweighing the benefits of vaccines (p-value < 0.001), distrust of vaccine companies (p-value < 0.001), usage of mask, gloves, and sanitizers (p-value < 0.001), contradictory speech of health authorities regarding vaccines (p-value = 0.041), and the unavailability of trusted vaccines (p-value = 0.002). It should also be noted that participants reported a greater likelihood to obtain information about vaccination reluctance from family and friends (p-value <0.001) and complementary medicine professionals (p-value <0.001).Avoiding vaccination is an undeniable public and individual health concern in Iran, as demonstrated in the current study. Concern about vaccine efficacy and side effects is the most reported cause of vaccination reluctance among individuals, which could be altered by emphasizing mass education and averting an infodemic by forming dedicated multidisciplinary organizations.CONCLUSIONAvoiding vaccination is an undeniable public and individual health concern in Iran, as demonstrated in the current study. Concern about vaccine efficacy and side effects is the most reported cause of vaccination reluctance among individuals, which could be altered by emphasizing mass education and averting an infodemic by forming dedicated multidisciplinary organizations. BackgroundVaccination is a crucial action that can end the COVID-19 pandemic and reduce its detrimental effect on public health. Despite the availability of various vaccines, this study was conducted to better understand the factors behind individuals refusing to get vaccinated.MethodThe current cross-sectional study was conducted with individuals above 18 years of age in Shiraz, Iran, who were eligible but refused to receive the COVID-19 vaccination. Demographic features and factors related to their hesitancy and willingness to participate in the vaccination program were recorded in a questionnaire.ResultOut of 801 participants in the current study, 427 (53.3%) were men, with a mean age of 37.92 years (± 14.16). The findings revealed that 350 (43.7%) participants claimed the side effects of the vaccine outweigh the benefits as one reason for their reluctance toward COVID-19 vaccination, followed by the unknown efficacy of vaccines (40.4%) and a lack of trust in vaccine companies (32.8%). Ensuring the safety of the vaccine (43.7%) and verifying its effectiveness (34.5%) were the most prevalent factors behind participating in the vaccination program. Those who reported their socio-economic status as low were significantly reluctant toward vaccination because of a self-presumption of high immunity (p-value < 0.001), the unclear efficacy of vaccines (p-value < 0.001), the side effects outweighing the benefits of vaccines (p-value < 0.001), distrust of vaccine companies (p-value < 0.001), usage of mask, gloves, and sanitizers (p-value < 0.001), contradictory speech of health authorities regarding vaccines (p-value = 0.041), and the unavailability of trusted vaccines (p-value = 0.002). It should also be noted that participants reported a greater likelihood to obtain information about vaccination reluctance from family and friends (p-value <0.001) and complementary medicine professionals (p-value <0.001).ConclusionAvoiding vaccination is an undeniable public and individual health concern in Iran, as demonstrated in the current study. Concern about vaccine efficacy and side effects is the most reported cause of vaccination reluctance among individuals, which could be altered by emphasizing mass education and averting an infodemic by forming dedicated multidisciplinary organizations. Vaccination is a crucial action that can end the COVID-19 pandemic and reduce its detrimental effect on public health. Despite the availability of various vaccines, this study was conducted to better understand the factors behind individuals refusing to get vaccinated. The current cross-sectional study was conducted with individuals above 18 years of age in Shiraz, Iran, who were eligible but refused to receive the COVID-19 vaccination. Demographic features and factors related to their hesitancy and willingness to participate in the vaccination program were recorded in a questionnaire. Out of 801 participants in the current study, 427 (53.3%) were men, with a mean age of 37.92 years (± 14.16). The findings revealed that 350 (43.7%) participants claimed the side effects of the vaccine outweigh the benefits as one reason for their reluctance toward COVID-19 vaccination, followed by the unknown efficacy of vaccines (40.4%) and a lack of trust in vaccine companies (32.8%). Ensuring the safety of the vaccine (43.7%) and verifying its effectiveness (34.5%) were the most prevalent factors behind participating in the vaccination program. Those who reported their socio-economic status as low were significantly reluctant toward vaccination because of a self-presumption of high immunity (p-value < 0.001), the unclear efficacy of vaccines (p-value < 0.001), the side effects outweighing the benefits of vaccines (p-value < 0.001), distrust of vaccine companies (p-value < 0.001), usage of mask, gloves, and sanitizers (p-value < 0.001), contradictory speech of health authorities regarding vaccines (p-value = 0.041), and the unavailability of trusted vaccines (p-value = 0.002). It should also be noted that participants reported a greater likelihood to obtain information about vaccination reluctance from family and friends (p-value <0.001) and complementary medicine professionals (p-value <0.001). Avoiding vaccination is an undeniable public and individual health concern in Iran, as demonstrated in the current study. Concern about vaccine efficacy and side effects is the most reported cause of vaccination reluctance among individuals, which could be altered by emphasizing mass education and averting an infodemic by forming dedicated multidisciplinary organizations. Vaccination is a crucial action that can end the COVID-19 pandemic and reduce its detrimental effect on public health. Despite the availability of various vaccines, this study was conducted to better understand the factors behind individuals refusing to get vaccinated. The current cross-sectional study was conducted with individuals above 18 years of age in Shiraz, Iran, who were eligible but refused to receive the COVID-19 vaccination. Demographic features and factors related to their hesitancy and willingness to participate in the vaccination program were recorded in a questionnaire. Out of 801 participants in the current study, 427 (53.3%) were men, with a mean age of 37.92 years (± 14.16). The findings revealed that 350 (43.7%) participants claimed the side effects of the vaccine outweigh the benefits as one reason for their reluctance toward COVID-19 vaccination, followed by the unknown efficacy of vaccines (40.4%) and a lack of trust in vaccine companies (32.8%). Ensuring the safety of the vaccine (43.7%) and verifying its effectiveness (34.5%) were the most prevalent factors behind participating in the vaccination program. Those who reported their socio-economic status as low were significantly reluctant toward vaccination because of a self-presumption of high immunity (p-value < 0.001), the unclear efficacy of vaccines (p-value < 0.001), the side effects outweighing the benefits of vaccines (p-value < 0.001), distrust of vaccine companies (p-value < 0.001), usage of mask, gloves, and sanitizers (p-value < 0.001), contradictory speech of health authorities regarding vaccines (p-value = 0.041), and the unavailability of trusted vaccines (p-value = 0.002). It should also be noted that participants reported a greater likelihood to obtain information about vaccination reluctance from family and friends (p-value <0.001) and complementary medicine professionals (p-value <0.001). Avoiding vaccination is an undeniable public and individual health concern in Iran, as demonstrated in the current study. Concern about vaccine efficacy and side effects is the most reported cause of vaccination reluctance among individuals, which could be altered by emphasizing mass education and averting an infodemic by forming dedicated multidisciplinary organizations. |
| Audience | Academic |
| Author | Raeisi Shahrakie, Hadi Rezaianzadeh, Abbas Bagheri Lankarani, Kamran Shahriarirad, Reza Hosseinpour, Parisa Maharlouei, Najmeh Erfani, Amirhossein |
| AuthorAffiliation | 1 Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran 5 Non-Communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran 3 Thoracic and Vascular Surgery Research Center, Shiraz University of Medical Sciences, Shiraz, Iran 2 School of Medicine, Islamic Azad University, Kazeroun Branch, Kazeroun, Iran The University of the West Indies, TRINIDAD AND TOBAGO 4 Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran |
| AuthorAffiliation_xml | – name: 2 School of Medicine, Islamic Azad University, Kazeroun Branch, Kazeroun, Iran – name: The University of the West Indies, TRINIDAD AND TOBAGO – name: 1 Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran – name: 3 Thoracic and Vascular Surgery Research Center, Shiraz University of Medical Sciences, Shiraz, Iran – name: 4 Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran – name: 5 Non-Communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran |
| Author_xml | – sequence: 1 givenname: Najmeh surname: Maharlouei fullname: Maharlouei, Najmeh – sequence: 2 givenname: Parisa surname: Hosseinpour fullname: Hosseinpour, Parisa – sequence: 3 givenname: Amirhossein orcidid: 0000-0001-9065-5083 surname: Erfani fullname: Erfani, Amirhossein – sequence: 4 givenname: Reza surname: Shahriarirad fullname: Shahriarirad, Reza – sequence: 5 givenname: Hadi surname: Raeisi Shahrakie fullname: Raeisi Shahrakie, Hadi – sequence: 6 givenname: Abbas surname: Rezaianzadeh fullname: Rezaianzadeh, Abbas – sequence: 7 givenname: Kamran surname: Bagheri Lankarani fullname: Bagheri Lankarani, Kamran |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36508442$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk11r2zAUhs3oWD-2fzA2QWFs0GSWbOujF4OQrVugEFi33ooTWU4UHCuR5G7Zr5-cpCUpZQxf2D563lfW63NOk6PGNjpJXuO0jzOGP85t6xqo-8tY7qeEcUHZs-QEi4z0KEmzo73n4-TU-3maFhmn9EVynNEi5XlOTpLVFahgnUfgvVUGgi7RLxNmyOm6VQEatUbBIlCr1jiNhuPb0eceFugOlDINBGObSzRAylnve16rrgA18qEt18g06GZmHPy5QCMHzQUiKSEvk-cV1F6_2t3Pkp9XX34Mv_Wux19Hw8F1T1FBQg-rImeUZ_ENFFFlLCpW4YKIyURozWheFWUKjOCUMk5ykVdQcBLXKqpEybOz5O3Wd1lbL3dpeUlYkRUso4JGYrQlSgtzuXRmAW4tLRi5KVg3leCCUbWWmOclw5OST7DKdcUET4GTCnLGQdByEr0-7XZrJwtdKt0EB_WB6eFKY2Zyau-kYPE_cBEN3u8MnF212ge5MF7puoZG23b73ZQynHfo-SP06dPtqCnEA5imsnFf1ZnKASOCFVikLFL9J6h4lXphVGytysT6geDDgSAyQf8OU2i9l6Ob7__Pjm8P2Xd77ExDHWbe1m3XUP4QfLOf9EPE9z0dgXwLbJrS6eoBwansRuc-LtmNjtyNTpRdPpIpEzYNHhMx9b_FfwGNdx2Q |
| CitedBy_id | crossref_primary_10_7189_jogh_14_05026 crossref_primary_10_3390_vaccines11010183 crossref_primary_10_1080_21645515_2024_2325230 crossref_primary_10_1136_bmjopen_2023_072326 crossref_primary_10_3390_vaccines11010074 crossref_primary_10_1016_j_gsd_2024_101342 crossref_primary_10_1371_journal_pone_0307336 crossref_primary_10_1186_s12887_023_04202_y crossref_primary_10_4103_aam_aam_13_23 |
| Cites_doi | 10.2147/PPA.S334757 10.1111/anae.15442 10.1016/j.puhe.2021.02.025 10.1136/postgradmedj-2021-141365 10.1038/s41586-020-2798-3 10.1371/journal.pone.0260731 10.3389/fpubh.2022.844333 10.3390/vaccines9030300 10.1093/aje/kwab293 10.1136/bmjgh-2020-004206 10.1371/journal.pone.0262192 10.1186/s12879-020-05128-x 10.1186/s13033-021-00445-3 10.1017/S1049023X21000777 10.1007/s11684-021-0893-y 10.11604/pamj.2021.38.3.27401 |
| ContentType | Journal Article |
| Copyright | Copyright: © 2022 Maharlouei et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. COPYRIGHT 2022 Public Library of Science 2022 Maharlouei et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022 Maharlouei et al 2022 Maharlouei et al |
| Copyright_xml | – notice: Copyright: © 2022 Maharlouei et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. – notice: COPYRIGHT 2022 Public Library of Science – notice: 2022 Maharlouei et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022 Maharlouei et al 2022 Maharlouei et al |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU COVID D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
| DOI | 10.1371/journal.pone.0278967 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts ProQuest Central Nursing & Allied Health database (via ProQuest) Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection ProQuest Central Health & Medical Collection (via ProQuest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials - QC Biological Science Collection ProQuest Central (via ProQuest) Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College Coronavirus Research Database ProQuest Materials Science Collection ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database (Proquest) Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) ProQuest Central Biological Science Database (via ProQuest) Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection Coronavirus Research Database ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Agricultural Science Database MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) Public Health |
| DocumentTitleAlternate | Associated factors of reluctancy toward COVID-19 vaccination |
| EISSN | 1932-6203 |
| ExternalDocumentID | 2753573696 oai_doaj_org_article_184d71bd8b1c4ef7980a82fa478a96db PMC9744289 A729751907 36508442 10_1371_journal_pone_0278967 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Iran |
| GeographicLocations_xml | – name: Iran |
| GrantInformation_xml | – fundername: ; grantid: 24974 |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM ADRAZ CGR CUY CVF ECM EIF IPNFZ NPM PJZUB PPXIY PQGLB RIG BBORY PMFND 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K COVID DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PKEHL PQEST PQUKI PRINS RC3 7X8 ESTFP PUEGO 5PM AAPBV ABPTK N95 |
| ID | FETCH-LOGICAL-c692t-1c547683c69ac2cd692c7f1529bb9ee764f5d0a72106782494fa582b9ef6c9d83 |
| IEDL.DBID | M48 |
| ISSN | 1932-6203 |
| IngestDate | Sun Feb 05 03:14:05 EST 2023 Wed Aug 27 01:25:48 EDT 2025 Thu Aug 21 18:39:42 EDT 2025 Fri Sep 05 14:49:33 EDT 2025 Fri Jul 25 10:19:30 EDT 2025 Tue Jun 17 21:26:03 EDT 2025 Tue Jun 10 20:35:23 EDT 2025 Fri Jun 27 03:58:31 EDT 2025 Fri Jun 27 05:04:06 EDT 2025 Thu May 22 21:32:54 EDT 2025 Mon Jul 21 05:32:24 EDT 2025 Tue Jul 01 04:31:52 EDT 2025 Thu Apr 24 23:06:44 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 12 |
| Language | English |
| License | Copyright: © 2022 Maharlouei et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c692t-1c547683c69ac2cd692c7f1529bb9ee764f5d0a72106782494fa582b9ef6c9d83 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Competing Interests: The authors have declared that no competing interests exist. |
| ORCID | 0000-0001-9065-5083 |
| OpenAccessLink | https://www.proquest.com/docview/2753573696?pq-origsite=%requestingapplication%&accountid=15518 |
| PMID | 36508442 |
| PQID | 2753573696 |
| PQPubID | 1436336 |
| PageCount | e0278967 |
| ParticipantIDs | plos_journals_2753573696 doaj_primary_oai_doaj_org_article_184d71bd8b1c4ef7980a82fa478a96db pubmedcentral_primary_oai_pubmedcentral_nih_gov_9744289 proquest_miscellaneous_2753667149 proquest_journals_2753573696 gale_infotracmisc_A729751907 gale_infotracacademiconefile_A729751907 gale_incontextgauss_ISR_A729751907 gale_incontextgauss_IOV_A729751907 gale_healthsolutions_A729751907 pubmed_primary_36508442 crossref_primary_10_1371_journal_pone_0278967 crossref_citationtrail_10_1371_journal_pone_0278967 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2022-12-12 |
| PublicationDateYYYYMMDD | 2022-12-12 |
| PublicationDate_xml | – month: 12 year: 2022 text: 2022-12-12 day: 12 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2022 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | pone.0278967.ref016 pone.0278967.ref037 O Benecke (pone.0278967.ref027) 2019; 6 P Soares (pone.0278967.ref032) 2021; 9 MS Rane (pone.0278967.ref036) 2022; 191 group Es (pone.0278967.ref029) 2022; 17 B Bagchi (pone.0278967.ref005) 2020 TJTLDH Burki (pone.0278967.ref023) 2019; 1 R Shahriarirad (pone.0278967.ref003) 2020; 20 M Heidari (pone.0278967.ref019) 2021; 36 VK Phadke (pone.0278967.ref026) 2016; 315 MR Hastall (pone.0278967.ref039) 2022 R Shahriarirad (pone.0278967.ref008) 2021; 15 M Askarian (pone.0278967.ref018) 2022; 21 S Umakanthan (pone.0278967.ref002) 2020; 96 World Health Organization (pone.0278967.ref028) 2019 S Umakanthan (pone.0278967.ref007) 2022; 2558 TM Cook (pone.0278967.ref015) 2021; 76 G Troiano (pone.0278967.ref021) 2021; 194 S Umakanthan (pone.0278967.ref006) 2022; 10 SL Wilson (pone.0278967.ref022) 2020; 5 pone.0278967.ref011 EJN Callaway (pone.0278967.ref013) 2020; 587 pone.0278967.ref004 K Puteikis (pone.0278967.ref030) 2021; 18 WC King (pone.0278967.ref034) 2021; 16 KA Fisher (pone.0278967.ref017) 2020; 173 S Umakanthan (pone.0278967.ref031) 2022; 98 J Eskola (pone.0278967.ref025) 2015; 33 F. Krammer (pone.0278967.ref010) 2020; 586 PR Mohapatra (pone.0278967.ref020) 2021; 21 S Umakanthan (pone.0278967.ref035) 2021; 9 AA Afolabi (pone.0278967.ref001) 2021; 38 SH Alzahrani (pone.0278967.ref033) 2021; 9 Z Huang (pone.0278967.ref038) 2022; 16 S Thanapluetiwong (pone.0278967.ref012) 2021; 15 MD Knoll (pone.0278967.ref014) 2021; 397 T VoPham (pone.0278967.ref009) 2020 pone.0278967.ref024 38995929 - PLoS One. 2024 Jul 12;19(7):e0307336. doi: 10.1371/journal.pone.0307336 |
| References_xml | – volume: 587 start-page: 337 issue: 7834 year: 2020 ident: pone.0278967.ref013 publication-title: COVID vaccine excitement builds as Moderna reports third positive result – ident: pone.0278967.ref024 – volume: 15 start-page: 2389 year: 2021 ident: pone.0278967.ref012 article-title: Factors associated with COVID-19 Vaccine Hesitancy in Thai Seniors. publication-title: Patient Prefer Adherence doi: 10.2147/PPA.S334757 – volume: 76 start-page: 608 issue: 5 year: 2021 ident: pone.0278967.ref015 article-title: Impact of vaccination by priority group on UK deaths, hospital admissions and intensive care admissions from COVID-19. publication-title: Anaesthesia. doi: 10.1111/anae.15442 – volume: 6 year: 2019 ident: pone.0278967.ref027 article-title: Anti-Vaccine Decision-Making and Measles Resurgence in the United States. publication-title: Glob Pediatr Health. – start-page: 1 year: 2022 ident: pone.0278967.ref039 article-title: Multidisciplinary expert group: communication measures to increase vaccine compliance in adults publication-title: Wien Med Wochenschr – volume: 33 start-page: 4215 issue: 34 year: 2015 ident: pone.0278967.ref025 publication-title: How to deal with vaccine hesitancy? – volume: 194 start-page: 245 year: 2021 ident: pone.0278967.ref021 article-title: Vaccine hesitancy in the era of COVID-19. publication-title: Public Health. doi: 10.1016/j.puhe.2021.02.025 – year: 2019 ident: pone.0278967.ref028 publication-title: Ten health issues WHO will tackle this year – volume: 98 start-page: 756 issue: 1164 year: 2022 ident: pone.0278967.ref031 article-title: Predictors of COVID-19 vaccine hesitancy in Germany: a cross-sectional, population-based study. publication-title: Postgrad Med J. doi: 10.1136/postgradmedj-2021-141365 – volume: 1 start-page: e258 issue: 6 year: 2019 ident: pone.0278967.ref023 publication-title: Vaccine misinformation and social media – volume: 173 start-page: 964 issue: 12 year: 2020 ident: pone.0278967.ref017 article-title: Mazor KMJAoim. Attitudes toward a potential SARS-CoV-2 vaccine: a survey of publication-title: US adults – start-page: 15 volume-title: Impact of COVID-19 on global economy year: 2020 ident: pone.0278967.ref005 – volume: 9 start-page: 1064 issue: 10 year: 2021 ident: pone.0278967.ref035 article-title: COVID-19 vaccine hesitancy and resistance in India explored through a population-based longitudinal survey. – volume: 586 start-page: 516 issue: 7830 year: 2020 ident: pone.0278967.ref010 article-title: SARS-CoV-2 vaccines in development publication-title: Nature doi: 10.1038/s41586-020-2798-3 – volume: 315 start-page: 1149 issue: 11 year: 2016 ident: pone.0278967.ref026 publication-title: Association between vaccine refusal and vaccine-preventable diseases in the United States: a review of measles and pertussis – volume: 16 start-page: e0260731 issue: 12 year: 2021 ident: pone.0278967.ref034 article-title: Time trends, factors associated with, and reasons for COVID-19 vaccine hesitancy: A massive online survey of US adults from January-May 2021. publication-title: PLoS One. doi: 10.1371/journal.pone.0260731 – volume: 10 start-page: 844333 year: 2022 ident: pone.0278967.ref006 article-title: The Commonwealth Caribbean COVID-19: Regions Resilient Pathway During Pandemic. publication-title: Front Public Health. doi: 10.3389/fpubh.2022.844333 – volume: 9 start-page: 300 issue: 3 year: 2021 ident: pone.0278967.ref032 article-title: Factors Associated with COVID-19 Vaccine Hesitancy. publication-title: Vaccines (Basel). doi: 10.3390/vaccines9030300 – volume: 191 start-page: 570 issue: 4 year: 2022 ident: pone.0278967.ref036 article-title: Determinants and Trends of COVID-19 Vaccine Hesitancy and Vaccine Uptake in a National Cohort of US Adults: A Longitudinal Study publication-title: Am J Epidemiol doi: 10.1093/aje/kwab293 – ident: pone.0278967.ref011 – volume: 5 start-page: e004206 issue: 10 year: 2020 ident: pone.0278967.ref022 article-title: Social media and vaccine hesitancy publication-title: BMJ Glob Health doi: 10.1136/bmjgh-2020-004206 – volume: 17 start-page: e0262192 issue: 1 year: 2022 ident: pone.0278967.ref029 article-title: The social specificities of hostility toward vaccination against Covid-19 in France. publication-title: PLoS One doi: 10.1371/journal.pone.0262192 – volume: 20 start-page: 427 issue: 1 year: 2020 ident: pone.0278967.ref003 article-title: Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran. publication-title: BMC Infect Dis doi: 10.1186/s12879-020-05128-x – volume: 15 start-page: 19 issue: 1 year: 2021 ident: pone.0278967.ref008 article-title: The mental health impact of COVID-19 outbreak: a Nationwide Survey in Iran. publication-title: Int J Ment Health Syst doi: 10.1186/s13033-021-00445-3 – volume: 397 start-page: 72 issue: 10269 year: 2021 ident: pone.0278967.ref014 publication-title: Oxford–AstraZeneca COVID-19 vaccine efficacy. – year: 2020 ident: pone.0278967.ref009 article-title: Effect of social distancing on COVID-19 incidence and mortality in the US. publication-title: medRxiv – volume: 36 start-page: 659 issue: 5 year: 2021 ident: pone.0278967.ref019 article-title: Challenges of COVID-19 Vaccination in Iran: In the Fourth Wave of Pandemic Spread. publication-title: Prehosp Disaster Med. doi: 10.1017/S1049023X21000777 – volume: 21 start-page: 599 issue: 5 year: 2021 ident: pone.0278967.ref020 publication-title: Regulatory approval of COVID-19 vaccine for restricted use in clinical trial mode. – ident: pone.0278967.ref004 – volume: 96 start-page: 753 issue: 1142 year: 2020 ident: pone.0278967.ref002 article-title: Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). publication-title: Postgrad Med J – volume: 2558 year: 2022 ident: pone.0278967.ref007 publication-title: The effect of statins on clinical outcome among hospitalized patients with COVID-19: a multi-centric cohort study – volume: 18 start-page: 4374 issue: 8 year: 2021 ident: pone.0278967.ref030 publication-title: Factors associated with COVID-19 vaccine hesitancy among people with epilepsy in Lithuania. – ident: pone.0278967.ref016 – volume: 9 start-page: 798 issue: 7 year: 2021 ident: pone.0278967.ref033 article-title: Attitudes toward the SARS-CoV-2 vaccine: results from the Saudi Residents’ Intention to Get Vaccinated against COVID-19 (SRIGVAC) study. – ident: pone.0278967.ref037 – volume: 21 start-page: 93 year: 2022 ident: pone.0278967.ref018 article-title: The COVID-19 vaccination acceptance/hesitancy rate and its determinants among healthcare workers of 91 Countries: A multicenter cross-sectional study. – volume: 16 start-page: 39 issue: 1 year: 2022 ident: pone.0278967.ref038 article-title: A review of the safety and efficacy of current COVID-19 vaccines. publication-title: Front Med. doi: 10.1007/s11684-021-0893-y – volume: 38 start-page: 3 year: 2021 ident: pone.0278967.ref001 article-title: Dealing with vaccine hesitancy in Africa: the prospective COVID-19 vaccine context. publication-title: Pan Afr Med J. doi: 10.11604/pamj.2021.38.3.27401 – reference: 38995929 - PLoS One. 2024 Jul 12;19(7):e0307336. doi: 10.1371/journal.pone.0307336 |
| SSID | ssj0053866 |
| Score | 2.463233 |
| Snippet | Vaccination is a crucial action that can end the COVID-19 pandemic and reduce its detrimental effect on public health. Despite the availability of various... Background Vaccination is a crucial action that can end the COVID-19 pandemic and reduce its detrimental effect on public health. Despite the availability of... BackgroundVaccination is a crucial action that can end the COVID-19 pandemic and reduce its detrimental effect on public health. Despite the availability of... Background Vaccination is a crucial action that can end the COVID-19 pandemic and reduce its detrimental effect on public health. Despite the availability of... |
| SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e0278967 |
| SubjectTerms | Adult Availability Biology and Life Sciences Consent Coronaviruses COVID-19 COVID-19 - epidemiology COVID-19 - prevention & control COVID-19 vaccines COVID-19 Vaccines - adverse effects Cross-Sectional Studies Drug-Related Side Effects and Adverse Reactions Effectiveness Evaluation FDA approval Female Gloves Health behavior Health facilities Humans Information sources Male Medicine and Health Sciences Morbidity Mortality Pandemics People and Places Polymerase chain reaction Population Public health Questionnaires Reluctance Sanitizers Side effects Social networks Social Sciences Socioeconomics Vaccination - adverse effects Vaccine efficacy Vaccines |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR1db9Mw0EJ94gUxvlYYYBASIC1b4zh2zFsZVCsSTGJs2ltkOzarVKWlaXng13MXu2FBk8YDT1Vz56a5O9-Hcx-EvDIy475SJsk1y_C0yiemKlSCrohmzHNV4dHA5y_i-Ix_usgvroz6wpyw0B44EO4QIpBKprDepJY7L1Ux0gXzmstCK1EZ1L4jNdoGU0EHwy4WIhbKZTI9jHw5WC5qd4Dv2lQ7V_6PIWr79XdaebCcL5rrXM6_MyevmKLJXXIn-pB0HP77Drnl6ntkJ-7Shr6JraTf3ic_JmGcDtWRC66iePJKV26-sWvUrHS9oNpiPrCjRyfn0w9JquhPbe0snBO-o2PaPkHStFlbeOe2Jy2d1fT0crbSv_bpFCzePmVgqR-Qs8nHb0fHSRyykFih2DpJbc4h5Mjgm7bMVnDRSg9WXRmjnJOC-7waaQgU0a5BsMa9zgsGMC-sqorsIRnUQNZdQj3LMulzW8A6bhh8GjNyWCkirONCD0m2pXhpYwdyHIQxL9vXahIikUDAEvlURj4NSdKtWoYOHDfgv0dmdrjYP7u9AFJVRqkqb5KqIXmOolCGYtROC5RjiZXI4ETBbV62GNhDo8Ykne960zTl9OT8H5BOv_aQXkckvwByWB0LI-CZsDdXD3OvhwmawPbAuyi4W6o0JYNYNJc4sRFWboX5evCLDow_iol3tVtsAo4QEuLoIXkUZL-jbIbePedsSGRvV_RI34fUs8u2hTlEsRD3qsf_g1dPyG2Ub8wxStkeGaxXG_cUPMW1edYqhd-onGay priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central (via ProQuest) dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjR1db9Mw0BrdCxJCbHysMMAgJEBatsZx4hgJoW6sWpHo0MamvUWOY2-VqqRrWh749dwlTkbQBDxVjS9tcne-L98HIW9SEXCbydQLFQswWmW9NIulh6aIYsxymWFo4OskOjrjXy7CizUyaWphMK2ykYmVoM4KjTHyPQZ2dShw-tyn-bWHU6PwdLUZoaHcaIXsY9Vi7A5ZB5EcDnpkff9w8u2kkc2wu6PIFdAFwt9z9NqdF7nZxTM4Wc2bv1FQVR__Vlr35rOivM0U_TOj8jcVNXpA7jvbkg5rZtggaybfJPfqwByt6402yYbbzSV951pOv39Irkf12B2qHLVMRjFCSxdmttJLlMB0WVClMW_Y0IPj8_Fnz5f0B2BkWscTP9Ahrd7IK6vsLnySqnctneb09Gq6UD936Bg04w5loNEfkbPR4feDI88NY_B0JNnS83XIwTUJ4JvSTGdwUQsL2l-mqTRGRNyG2UCBQ4n6D5w6blUYM1izkZZZHDwmvRzQvEWoZUEgbKhjuI-nDD7TdGCwoiTShkeqT4KGAol2ncpxYMYsqY7fBHgsNUITpFvi6NYnXnvXvO7U8Q_4fSRuC4t9tqsLxeIycds2Af83Ez5wb-prbqyQ8UDFzCouYiWjLO2Tl8gaSV202kqLZCiwYhmMLfib1xUE9trIMZnnUq3KMhkfn_8H0OlJB-itA7IFoEMrV0AB74Q9vDqQ2x1IkBi6s7yFjNxgpUxu9hbc2TD37cuv2mX8UUzQy02xqmGiSIC_3SdP6r3QYjZAL4Bz1ieis0s6qO-u5NOrqtU5eLvgH8unf3-sZ-Quci5mGflsm_SWi5V5DrbiMn3hBMAvWZxpOA priority: 102 providerName: ProQuest |
| Title | Factors associated with reluctancy to acquire COVID-19 vaccination: A cross-sectional study in Shiraz, Iran, 2022 |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/36508442 https://www.proquest.com/docview/2753573696 https://www.proquest.com/docview/2753667149 https://pubmed.ncbi.nlm.nih.gov/PMC9744289 https://doaj.org/article/184d71bd8b1c4ef7980a82fa478a96db http://dx.doi.org/10.1371/journal.pone.0278967 |
| Volume | 17 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELe27oUXxPhaYRSDkABpqRrHiWMkhLqysiKxoY1NfYscx94qVWnXtAj467lz0oig8vGSKPE5kc9n3_3s8x0hL1IRcJvJ1AsVC3C1ynppFksPTRHFmOUyw6WBTyfR8QX_OA7HW2Sds7ViYLER2mE-qYvFtPvt5vs7GPBvXdYG4a8rdeez3HRxJ01GYpvsuB0jdObj9b4CjG63e4lWixexXlAdpvvTVxrKysX0r2fu1nw6KzaZpb97V_6iroZ3yO3KzqT9UjB2yZbJ75LdaiQX9FUVbvr1PXIzLFPuUFX1lMkors7ShZmu9BJnX7qcUaXRZ9jQwenl6L3nS_pVaT0p1xLf0D51LfAK59mFf3Zxa-kkp-fXk4X6cUBHoBUPKANtfp9cDI--DI69KhGDpyPJlp6vQw6wJIAnpZnO4KUWFjS_TFNpjIi4DbOeAjCJug8AHbcqjBmU2UjLLA4ekFYObN0j1LIgEDbUMdTjKYN7mvYMniaJtOGRapNgzfFEV1HKMVnGNHFbbwLQSsnABPspqfqpTby61ryM0vEP-kPszJoWY2y7F7PFVVIN2QSwbyZ8kNzU19xYIeOeiplVXMRKRlnaJk9RFJLywGo9UyR9gaeVwdCC3zx3FBhnI0dHniu1KopkdHr5H0TnZw2ilxWRnQE7tKoOT0CbMH5Xg3K_QQmzhW4U76HgrrlSJAzwaigwqyPUXAvz5uJndTF-FJ3zcjNblTRRJABrt8nDUvZrzgaIADhnbSIao6LB-mZJPrl2Yc4B6QI2lo_-3qDH5BZKLnoY-WyftJaLlXkCduIy7ZBtMRZwjQc-XocfOmTn8Ojk81nHrbx03NTwEx-fajw |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1rb9Mw0BrdB5AQYuOxwmAGgQBp2RrHiROkCXWPqmVbN-2lfQuO42yVqqRrWhD8OH4bd4nTETQBX_apanzOw3e-l-9ByJtIODyJg8hyJXPQW5VYUewHFqoikrGEBzG6Bvb7XveUfz53z-fIzyoXBsMqK55YMOo4U-gjX2egV7sCu899Gl1Z2DUKT1erFhrStFaIN4oSYyaxY1d__wYmXL7R2wZ8v2Wss3Oy1bVMlwFLeQGbWLZyOejcDvyTiqkYLiqRgFgLoijQWng8ceOWBEsJGTtYKzyRrs9gLPFUEPsO3PcOmefoQGmQ-c2d_uFRJQuAm3ieSdhzhL1u6GNtlKV6Dc_8gqK__bVALPoGzKRDYzTM8ptU3z8jOH8TiZ2H5IHRZWm7JL4FMqfTRXK_dATSMr9pkSwY7pHT96bE9YdH5KpTtvmh0lCHjil6hOlYD6dqghyfTjIqFcYpa7p1cNbbtuyAfgUMDEr_5UfapsUXWXkRTYZvUtTKpYOUHl8OxvLHKu2BJF6lDDSIx-T0VtDyhDRSWOYlQhPmOCJxlQ_zeMTgN4paGjNYPKW5J5vEqTAQKlMZHRt0DMPiuE-AhVQuaIh4Cw3emsSazRqVlUH-Ab-JyJ3BYl3v4kI2vggNmwjB3o6FDbslshXXiQj8lvRZIrnwZeDFUZOsIGmEZZLsjDuFbYEZ0qDcwWNeFxBY2yPF4KELOc3zsHdw9h9Ax0c1oHcGKMlgOZQ0CRvwTVgzrAa5XIMEDqVqw0tIyNWq5OH1XoaZFXHfPPxqNow3xYDAVGfTEsbzBNj3TfK03AuzlXXQ6uCcNYmo7ZLa0tdH0sFlUVodrGuwx4Nnf3-tFXK3e7K_F-71-rvPyT2kYoxwstkyaUzGU_0C9NRJ9NIwA0q-3Db_-QUjnKV7 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1rb9Mw0BpFQkgIsfFYYTCDQIC0rI3jxAkSQmWjWhlsE2NTvwXHsbdKVdI1LQh-Gr-Ou8TNCJqAL_tUNb48fHc-353vQcjTRHjcpFHi-JJ56K0yTpKGkYOqiGTM8ChF18DHvWDniL8f-sMl8nORC4NhlQuZWArqNFfoI-8w0Kt9gd3nOsaGRRxs999MzhzsIIUnrYt2GhWL7Orv38B8K14PtoHWzxjrv_u8tePYDgOOCiI2c1zlc9C3PfgnFVMpXFTCwJYWJUmktQi48dOuBCsJhTpYKtxIP2QwZgIVpaEHz71CrsJ8ObaNEMPa2AM5EgQ2Vc8TbsdyxuYkz_QmnvZFZWf7862w7BhQ7wutyTgvLlJ6_4zd_G0z7N8iN60WS3sV2y2TJZ2tkBuVC5BWmU0rZNnKjYK-sMWtX94mZ_2qwQ-Vli90StEXTKd6PFczlPV0llOpMEJZ063948G240b0q1RqVHkuX9EeLWfkFGUcGX5JWSWXjjJ6eDqayh8bdAB78AZloDvcIUeXQpS7pJUBmlcJNczzhPFVCPfxhMFvknQ15q4ESvNAtom3oECsbE10bM0xjsuDPgG2UYXQGOkWW7q1iVPfNalqgvwD_i0St4bFit7lhXx6ElsBEYOlnQoX1kniKq6NiMKuDJmRXIQyCtKkTdaRNeIqPbaWS3FPYG40qHXwmiclBFb1yHB9nMh5UcSD_eP_ADr81AB6boFMDuhQ0qZqwJywWlgDcq0BCbJJNYZXkZEXWCni81UMdy6Y--Lhx_UwPhRDATOdzyuYIBBg2bfJvWot1Jj10N7gnLWJaKySBuqbI9notCyqDnY1WOLR_b9_1jq5BlIn_jDY231AriMTY2iTy9ZIazad64egoM6SR6UkoOTLZYueX6I2oxc |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Factors+associated+with+reluctancy+to+acquire+COVID-19+vaccination%3A+A+cross-sectional+study+in+Shiraz%2C+Iran%2C+2022&rft.jtitle=PloS+one&rft.au=Maharlouei%2C+Najmeh&rft.au=Hosseinpour%2C+Parisa&rft.au=Erfani%2C+Amirhossein&rft.au=Shahriarirad%2C+Reza&rft.date=2022-12-12&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=17&rft.issue=12&rft.spage=e0278967&rft_id=info:doi/10.1371%2Fjournal.pone.0278967&rft.externalDocID=A729751907 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |